Literature DB >> 11821747

No recurrence of posttransplantation Kaposi's sarcoma three years after renal retransplantation.

Sylvie Euvrard1, Jean Kanitakis, Sylvie Bosshard, Céleste Lebbé, Jeanne-Luce Garnier, Jean-Louis Touraine, Alain Claudy.   

Abstract

Kaposi's sarcoma (KS) develops in 0.5-5% of organ transplant patients; it usually regresses upon treatment reduction, but this may result in graft loss necessitating return to dialysis and/or retransplantation. Until now posttransplantation KS is considered to recur upon reintroduction of immunosuppressive treatment, a fact that has limited retransplantation of patients with previous KS. We report a patient with posttransplantation KS who received a second renal transplantation after having been off immunosuppressive treatment for 10 years, in whom KS has not recurred more than 3 years after retransplantation. This unique observation suggests that retransplantation of patients with previous posttransplantation KS is possible.

Entities:  

Mesh:

Year:  2002        PMID: 11821747     DOI: 10.1097/00007890-200201270-00025

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

Review 1.  Incidence, risk factors and outcome of de novo tumors in liver transplant recipients focusing on alcoholic cirrhosis.

Authors:  Carlos Jiménez-Romero; Iago Justo-Alonso; Félix Cambra-Molero; Jorge Calvo-Pulido; Álvaro García-Sesma; Manuel Abradelo-Usera; Oscar Caso-Maestro; Alejandro Manrique-Municio
Journal:  World J Hepatol       Date:  2015-05-08

2.  Kaposi's sarcoma in a patient with severe relapsing polychondritis.

Authors:  Mona K Manghani; Jacqueline Andrews; Clare S Higgens
Journal:  Rheumatol Int       Date:  2003-12-05       Impact factor: 2.631

Review 3.  Assessment of kidney transplant suitability for patients with prior cancers: is it time for a rethink?

Authors:  Wai H Lim; Eric Au; Anoushka Krishnan; Germaine Wong
Journal:  Transpl Int       Date:  2019-08-28       Impact factor: 3.782

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.